Trial · NCT00858689
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 23
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Baseline of ABC Irritability Subtest Score at 8 Weeks | Baseline and 8 weeks | The 15-item Irritability Scale includes questions about aggression, self-injury, tantrums, agitation, and unstable mood on a scale of 0 to 45 with higher scores indicating greater severity. This scale has been successfully used in previous medication studies in children with autism and in patients with FXS and in a controlled trial of ampakine CX516 in FXS. All ABC subscales showed good reliability when used by parents and caregivers of individuals with FXS to assess behavior in the CX516 study NCT00054730, and yielded intraclass correlation coefficient (ICC) values of 0.7-0.9. |
| Primary | ABC Irritability Subtest Score | 8 weeks | ABC Irritability subtest score was used |
| Primary | ABC Irritability Subtest Score | 1 year | ABC (Aberrant behavior checklist) Irritability subtest score was used |
| Secondary | Parent Defined Target Symptoms Scale-Visual | Baseline | |
| Secondary | Clinical Global Impression Scale | Baseline | |
| Secondary | Stanford Binet 5 (SB5) | Baseline | |
| Secondary | The Peabody Picture Vocabulary Test Third Edition (PPVT-III) | Baseline | |
| Secondary | The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) | Baseline | |
| Secondary | Non-Verbal Associative Learning Task (NVALT) | Baseline | |
| Secondary | Vineland Adaptive Behaviour Scales (VABS) | Baseline | |
| Secondary | Parent Defined Target Symptoms Scale-Visual | 8 weeks | |
| Secondary | Parent Defined Target Symptoms Scale-Visual | 1 year | |
| Secondary | Clinical Global Impression Scale | 8 weeks | |
| Secondary | Clinical Global Impression Scale | 1 year | |
| Secondary | Stanford Binet 5 (SB5) | 1 year | |
| Secondary | The Peabody Picture Vocabulary Test Third Edition (PPVT-III) | 8 weeks | |
| Secondary | The Peabody Picture Vocabulary Test Third Edition (PPVT-III) | 1 year | |
| Secondary | The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) | 8 weeks | |
| Secondary | The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) | 1 year | |
| Secondary | Non-Verbal Associative Learning Task (NVALT) | 8 weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00858689/registered